BioCentury | Dec 3, 2007
Company News

Harvard University endocrine, metabolic, cardiovascular news

...CEO of the newco, which will be located in Cambridge. Jurgen Lehmann, formerly CSO of CareX S.A....
BioCentury | Dec 11, 2006
Strategy

Antibody plucking

...development at Actelion Ltd. (SWX:ATLN, Allschwil, Switzerland), as well as Geoff Race, formerly CEO of CareX S.A....
BioCentury | Dec 11, 2006
Company News

PanGenetics management update

...Utrecht, the Netherlands Business: Autoimmune, Cancer, Antibodies Hired: Geoff Race as CFO, formerly CEO of CareX S.A....
BioCentury | May 29, 2006
Strategy

Going for aggregation

...were not disclosed, including how much of the newco will be owned by CareX shareholders. CareX...
...to sell the company." Instead, several companies approached CareX looking to partner the CB1 program. CareX's...
...Denmark) does not plan on retaining CareX's Strasbourg operations, and will relocate key CareX researchers. CareX...
BioCentury | May 29, 2006
Company News

CareX, 7TM deal

...7TM acquired CareX for an undisclosed amount of stock. The deal adds CareX’s cannabinoid CB1 receptor...
...trial for obesity and is expected to begin Phase IIa testing in the fourth quarter. CareX S.A....
BioCentury | May 25, 2006
Company News

7TM acquires CareX

...fellow metabolic company CareX (Strasbourg, France) for an undisclosed amount of stock. The deal adds CareX's...
BioCentury | Mar 1, 2005
Financial News

Index closes EUR 300M fund

...investments include 7TM Pharma (Copenhagen, Denmark); Addex (Geneva, Switzerland); AlgoRx (Cranbury, N.J.); BioXell (Milan, Italy); CareX...
BioCentury | Jan 3, 2005
Finance

Ebb & Flow

...Germany. BioMedinvest's investments include cancer and autoimmune company Glycart ; functional genomics and metabolic play CareX...
BioCentury | Dec 23, 2004
Financial News

Hosang joins BioMedinvestor

...BioMedinvest's investments include cancer and autoimmune company Glycart (Zurich, Switzerland); functional genomics and metabolic play CareX...
BioCentury | Jun 14, 2004
Product Development

PPAR pipeline

...Ph I NA Plexxikon PLX204 PPAR gamma, alpha and delta agonist Preclin Submit IND 4Q04 CareX...
Items per page:
1 - 10 of 19
BioCentury | Dec 3, 2007
Company News

Harvard University endocrine, metabolic, cardiovascular news

...CEO of the newco, which will be located in Cambridge. Jurgen Lehmann, formerly CSO of CareX S.A....
BioCentury | Dec 11, 2006
Strategy

Antibody plucking

...development at Actelion Ltd. (SWX:ATLN, Allschwil, Switzerland), as well as Geoff Race, formerly CEO of CareX S.A....
BioCentury | Dec 11, 2006
Company News

PanGenetics management update

...Utrecht, the Netherlands Business: Autoimmune, Cancer, Antibodies Hired: Geoff Race as CFO, formerly CEO of CareX S.A....
BioCentury | May 29, 2006
Strategy

Going for aggregation

...were not disclosed, including how much of the newco will be owned by CareX shareholders. CareX...
...to sell the company." Instead, several companies approached CareX looking to partner the CB1 program. CareX's...
...Denmark) does not plan on retaining CareX's Strasbourg operations, and will relocate key CareX researchers. CareX...
BioCentury | May 29, 2006
Company News

CareX, 7TM deal

...7TM acquired CareX for an undisclosed amount of stock. The deal adds CareX’s cannabinoid CB1 receptor...
...trial for obesity and is expected to begin Phase IIa testing in the fourth quarter. CareX S.A....
BioCentury | May 25, 2006
Company News

7TM acquires CareX

...fellow metabolic company CareX (Strasbourg, France) for an undisclosed amount of stock. The deal adds CareX's...
BioCentury | Mar 1, 2005
Financial News

Index closes EUR 300M fund

...investments include 7TM Pharma (Copenhagen, Denmark); Addex (Geneva, Switzerland); AlgoRx (Cranbury, N.J.); BioXell (Milan, Italy); CareX...
BioCentury | Jan 3, 2005
Finance

Ebb & Flow

...Germany. BioMedinvest's investments include cancer and autoimmune company Glycart ; functional genomics and metabolic play CareX...
BioCentury | Dec 23, 2004
Financial News

Hosang joins BioMedinvestor

...BioMedinvest's investments include cancer and autoimmune company Glycart (Zurich, Switzerland); functional genomics and metabolic play CareX...
BioCentury | Jun 14, 2004
Product Development

PPAR pipeline

...Ph I NA Plexxikon PLX204 PPAR gamma, alpha and delta agonist Preclin Submit IND 4Q04 CareX...
Items per page:
1 - 10 of 19